Inosine Pranobex Market

Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
Inosine Pranobex Market contains market size and forecasts of Inosine Pranobex in global, including the following market information:
Global Inosine Pranobex Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Inosine Pranobex Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Inosine Pranobex companies in 2021 (%)
The global Inosine Pranobex market was valued at 206.8 million in 2021 and is projected to reach US$ 239.3 million by 2028, at a CAGR of 2.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inosine Pranobex include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andr?maco, Yung Shin, Alfasigma S.p.A., Polfarmex and Sanfer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inosine Pranobex manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inosine Pranobex Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inosine Pranobex Market Segment Percentages, by Type, 2021 (%)
Tablet
Syrup
Global Inosine Pranobex Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inosine Pranobex Market Segment Percentages, by Application, 2021 (%)
Immunomodulation
Antiviral
Other
Global Inosine Pranobex Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Inosine Pranobex Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inosine Pranobex revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Inosine Pranobex revenues share in global market, 2021 (%)
Key companies Inosine Pranobex sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Inosine Pranobex sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andr?maco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm